摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,5-dicyclohexyl-1-phenylphosphole | 448901-38-0

中文名称
——
中文别名
——
英文名称
2,5-dicyclohexyl-1-phenylphosphole
英文别名
1-phenyl-2,5-dicyclohexylphosphole
2,5-dicyclohexyl-1-phenylphosphole化学式
CAS
448901-38-0
化学式
C22H29P
mdl
——
分子量
324.446
InChiKey
WPSKRKJVUXBPKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.4
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

反应信息

  • 作为反应物:
    描述:
    2,5-dicyclohexyl-1-phenylphospholelithium 、 aluminum (III) chloride 作用下, 以 四氢呋喃 为溶剂, 生成
    参考文献:
    名称:
    锇的制备η 5个-Phospholide配合物及其与酰基电体的反应:C = O键的断裂和C-C键形成的金属配位层内
    摘要:
    两个diphosphaosmocene物种由锂2,5- dialkylphospholide的反应被预缩减以优良产率(烷基=环己基,( - ) -薄荷基)和[(η 6 -cymene)OSCL 2 ] 2的THF溶液。这些是具有core核的磷酸金属茂的第一个实例。对于成功的磷茂茂合成,至关重要的是使用空间需求的磷化物。用二氯甲烷中的AcCl / AlCl 3混合物处理2,2',5,5'-Cy 4-二磷茂茂,通过乙酰基C═O双键的活化产生新型(μ-亚乙烯基)os配合物。在锇络合物,锇原子和η的磷之间的μ -偏二部分桥4 - (P-氧代磷化物)。在过量的乙酰基亲电试剂的存在下,使μ-亚乙烯基络合物在μ-亚乙烯基部分的CH 2末端进一步乙酰化,得到(μ-乙酰基亚乙烯基)os络合物。在此转化过程中逐步应用乙酰氯和苯乙酰氯,可以通过在两个不同的酰氯之间形成C-C键来生产[μ-(苯乙酰基)亚乙烯基] os。
    DOI:
    10.1021/om101060n
点击查看最新优质反应信息

文献信息

  • Synthesis and Characterization of 1,1‘-Diphospharuthenocenes
    作者:Masamichi Ogasawara、Takashi Nagano、Kazuhiro Yoshida、Tamio Hayashi
    DOI:10.1021/om020189i
    日期:2002.7.1
    Reaction of [RuCl2(cod)](n) (cod = 1,5-cyclooctadiene) with lithium 2,5-dialkylphospholide or 1-stannyl-2,5-dialkylphosphole gives Ru(eta(5)-PC4H2-2,5-R-2)(2) (R = (-)-menthyl, 4a; or cyclohexyl, 4b). Steric bulkiness of the R groups is a crucial factor for the successful preparation of the 1,1'-diphospharuthenocenes. The structure of the complex 4b was studied by X-ray single-crystal structure determination, which clarified the distance between the nearly planar eta(5)-phospholyl ligand and the ruthenium center in the complex, being 1.811 Angstrom.
  • Coordination behavior of phosphino-phosphaferrocenes: monodentate versus bidentate coordination to divalent palladium
    作者:Masamichi Ogasawara、Yonghui Ge、Kiyohiko Nakajima、Tamotsu Takahashi
    DOI:10.1016/j.ica.2004.05.019
    日期:2004.11
    Two novel phosphino-phosphaferrocenes [eta(5)-C5H4(CH2)(n)PPh2]Fe(eta(5)-PC4H2-2,5-cy(2)) (PP1: n = 1; PP2: n = 2) have been designed and prepared in order to clarify weak chelate effect in the previously reported (eta(5)-C5H4CH2PPh2)Fe[eta(5)-PC4H2-2,5-((-)-menthyl)(2)] (1). P-31 NMR studies of reactions of PP1 with PdCl2(cod) (6) revealed that PP1 showed stronger tendency to coordinate to the Pd-II center in bidentate fashion compared to 1. On the other hand, chelate effect in PP2 was negligibly weak and a reaction of PP2 with 6 in a PP2/6 = 2/1 molar ratio gave a complex PdCl2(PP2)(2) (10) cleanly in which PP2 coordinated to the palladium center at the PPh2 moiety as a monodentate ligand. X-ray crystal structure studies of chelate complexes PdCl(2()PP1) (7) and PdCl2(PP2) (9) showed that 9 had deviations from an idealized geometry in the square planar complex which could be attributed to a larger chelate ring of PP2, while PP1 in 7 constructed nearly ideal geometry for the square planar complex.From comparison of the coordination behavior between 1, PP1, and PP2, it is concluded that steric bulk of (-)-menthyl groups in I is the main factor of the weak chelate coordination of 1. (C) 2004 Elsevier B.V. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫